NCT02348476View on ClinicalTrials.gov

A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
OTHER

No Intervention

No study drug is administered in this study.

Trial Locations (1)

Unknown

Wheaton

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY